Proteomics InternationalLaboratories LtdIgnite Investment SummitDisciplined Path to Commercial Success14 October 2026ASX: PIQ | ACN: 169 979 971 | Perth, Western Australia DisclaimerThis Presentation is provided by Proteomics International Laboratories Ltd (Proteomics International, Proteomics,...
Ignite Investment Summit Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
In the deck
Earlier from Proteomics International Laboratories
- PromarkerEndo Validation and Refinement Complete
- Notice of AGM Date
- Investor Presentation
- PromarkerD and PromarkerEso Commercial Rollout Update
- Appendix 4E and Annual Report
Later from Proteomics International Laboratories
- Proteomics International receives $2.0m in R&D tax incentive
- Notice of Annual General Meeting/Proxy Form
- National Rollout of PromarkerD and PromarkerEso
- Quarterly Activities/Appendix 4C Cash Flow Report
- Proteomics International Launches Share Purchase Plan
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories